Related Experiment Video
Updated: Aug 15, 2025
Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages
Published on: June 23, 2013
In Vitro Methods to Evaluate Macrophage Polarization and Function in Cancer
Aldo Ummarino1,2, Clément Anfray3, Akihiro Maeda1
1Department of Immunology, Humanitas Clinical and Research Center-IRCCS, Rozzano, Italy.
Abstract:
Tumor-associated macrophages (TAMs) play a key immunosuppressive role that limits the ability of the immune system to fight cancer and hinder the anti-tumoral efficacy of most treatments currently applied in the clinic. However, a key feature of macrophages is their phenotypical and functional plasticity, which called their attention as promising targets for therapeutic intervention based on their elimination or reprogramming toward M1-like cytotoxic effector cells, with anti-tumor functions. This polarization status of macrophages can be studied in terms of molecular markers and functional activities, using an appropriate combination of experimental methodologies, both in vitro and in vivo. Here we focus on describing in vitro protocols to isolate primary monocytes from buffy coats and to study macrophage phenotype and function, after exposure to new therapies, by a combination of flow cytometry, RT-PCR, and ELISA analysis. We also provide the methodology to evaluate in vitro the cytotoxic activity of treated macrophages toward cancer cells.
Insights
Tumor-associated macrophages (TAMs) suppress anti-cancer immunity. This study details in vitro methods to reprogram TAMs into anti-tumor effector cells, offering new therapeutic strategies.
Area of Science:
- Immunology
- Cancer Biology
- Cellular Therapeutics
Background:
- Tumor-associated macrophages (TAMs) exhibit immunosuppressive functions, hindering cancer immunity and treatment efficacy.
- Macrophage plasticity presents a therapeutic target for reprogramming towards anti-tumor phenotypes.
- Understanding TAM polarization is crucial for developing novel cancer therapies.
Purpose of the Study:
- To describe in vitro protocols for isolating and analyzing primary human monocytes and macrophages.
- To detail methods for assessing macrophage phenotype and function following exposure to novel therapies.
- To establish a protocol for evaluating the in vitro cytotoxic activity of treated macrophages against cancer cells.
Main Methods:
- Isolation of primary monocytes from buffy coats.
- Flow cytometry, RT-PCR, and ELISA for analyzing macrophage phenotype and function.
- In vitro assessment of cytotoxic activity of macrophages against cancer cells.
Main Results:
- Established protocols for monocyte isolation and macrophage differentiation.
- Demonstrated methods for evaluating therapeutic effects on macrophage polarization and function.
- Validated a system for assessing macrophage-mediated cancer cell killing.
Conclusions:
- The described in vitro protocols enable robust analysis of macrophage responses to therapeutic interventions.
- Reprogramming TAMs towards an M1-like phenotype is a viable strategy for enhancing anti-tumor immunity.
- These methodologies facilitate the development and validation of novel immunotherapies for cancer treatment.
